Latest stories on ONC
BeOne Medicines price target raised to $415 from $407 at Barclays
The Fly63 · neutralanalyst
FDA Approval Marks A Turning Point For BeOne Medicines (ONC)
Yahoo Top88 · bullishproduct/pr
BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
StockTitan56 · neutralgeneral
Trump Administration Reaches Most-Favored-Nation Drug Pricing Deals With 9 Companies
Morningstar50 · neutralpotus
BeOne Medicines to expand access to cancer medicines under pact with U.S.
The Fly63 · neutralproduct/pr
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
StockTitan63 · neutralgeneral
BeOne Medicines announces new Phase 3 survival data on Ziihera
The Fly63 · neutralproduct/pr
BeOne Medicines Ltd. (BEIGF) files 8-K
SEC 8-K50 · neutralgeneral
JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy
Stocktwits News67 · bullishproduct/pr
BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
StockTitan73 · bullishproduct/pr
BeOne Medicines Takes Aim at Hard-To-Treat Childhood Leukemia With New Sonrotoclax Trial
TipRanks63 · neutralproduct/pr
BeOne Medicines renews partnerships to expand access to Brukinsa in leukemia
The Fly63 · neutralproduct/pr
Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?
Yahoo Top67 · bullishm&a
BeOne Medicines (ONC) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Can Revolution Medicines (RVMD) Turn A New Ally Into Global Reach?
Yahoo Finance67 · bullishproduct/pr
BeOne Medicines price target raised to $370 from $340 at Wolfe Research
The Fly61 · neutralanalyst
ONC and Revolution Medicines Forge Key Deal: Exclusive RAS(ON) Inhibitor Rights in Asia and Combination Trials Shape Future Oncology Roadmap
MarketChameleon67 · bullishproduct/pr
BeOne Medicines partners with Revolution Medicines for clinical development
The Fly66 · bullishproduct/pr
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
StockTitan56 · neutralproduct/pr
Beone Medicines Price Target Raised To 405 From 395 At Morgan Stanley
The Fly61 · neutralanalyst
Guggenheim raises BeOne Medicines stock price target on revenue beat
Investing.com Analyst Ratings61 · neutralanalyst